Biomedical Engineering Reference
In-Depth Information
[99]
Grumont, R.J., Rourke, I.J., O'Reilly, L.A.
et al., B lymphocytes differentially use
the Rel and nuclear factor kappaB1 (NF-kappaB1) transcription factors to regulate
cell cycle progression and apoptosis in quiescent and mitogen-activated cells,
J. Exp.
Med.,
187, 663, 1998.
[100]
Owyang, A.M., Tumang, J.R., Schram, B.R.
et al., c-Rel is required for the protection
of B cells from antigen receptor-mediated, but not Fas-mediated, apoptosis,
J. Immu-
nol.,
167, 4948, 2001.
[101]
Li, Z.W., Omori, S.A., Labuda, T.
et al., IKK beta is required for peripheral B cell
survival and proliferation,
J. Immunol.,
170, 4630, 2003.
[102]
Prendes, M., Zheng, Y., and Beg, A.A., Regulation of developing B cell survival by
RelA-containing NF-kappaB complexes,
J. Immunol.,
171, 3963, 2003.
[103]
Kraus, M., Alimzhanov, M.B., Rajewsky, N.
et al., Survival of resting mature B
lymphocytes depends on BCR signaling via the Igalpha/beta heterodimer,
Cell,
117,
787, 2004.
[104]
Thome, M., CARMA1, BCL-10 and MALT1 in lymphocyte development and acti-
vation,
Nat. Rev. Immunol.,
4, 348, 2004.
